S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q4 2024

Baker Bros Advisors

Periodo: Q4 2024 · Depositato: 2025-02-14
Vedi su SEC EDGAR
AUM
$9.36B
Valore totale del portafoglio
Posizioni
95
Titoli dichiarati
Prima Posizione
INCY
22.7% $2.12B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-02-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
INCYIncyte Corporation$2.12B22.68%$69.07$116.86+69.2%
22.7%
ONCBeiGene, Ltd.$1.76B18.81%$184.71$297.65+61.1%
18.8%
ACADACADIA Pharmaceuticals Inc.$786.8M8.40%$18.35$25.97+41.5%
8.4%
MDGLMadrigal Pharmaceuticals, Inc.$609.3M6.51%$308.57$528.10+71.1%
6.5%
SMMTSummit Therapeutics Inc.$435.9M4.66%$17.84$15.42-13.6%
4.7%
RVMDRevolution Medicines, Inc.$347.2M3.71%$43.74$189.24+332.6%
3.7%
INSMInsmed Incorporated$345.7M3.69%$69.04$111.60+61.6%
3.7%
RYTMRhythm Pharmaceuticals, Inc.$340.6M3.64%$55.98$114.17+104.0%
3.6%
KYMRKymera Therapeutics, Inc.$241.2M2.58%$40.23$113.51+182.2%
2.6%
KODKodiak Sciences Inc.$172.2M1.84%$9.95$38.54+287.3%
1.8%
EWTXEdgewise Therapeutics, Inc.$164.4M1.76%$26.70$39.56+48.2%
1.8%
BCYCBicycle Therapeutics plc$152.4M1.63%$14.00$4.35-68.9%
1.6%
REPLReplimune Group, Inc.$133.8M1.43%$12.11$11.58-4.4%
1.4%
ALKSAlkermes plc$120.3M1.28%$28.76$54.58+89.8%
1.3%
Insmed Incorporated$92.9M0.99%
1.0%
TRDAEntrada Therapeutics, Inc.$84.1M0.90%$17.29$7.72-55.4%
0.9%
ABCLAbCellera Biologics Inc.$80.7M0.86%$2.93$8.11+176.8%
0.9%
DNLIDenali Therapeutics Inc.$76.0M0.81%$20.38$25.83+26.7%
0.8%
NRIXNurix Therapeutics, Inc.$73.1M0.78%$18.84$23.97+27.2%
0.8%
ARGXargenx SE$68.8M0.74%$615.00$939.68+52.8%
0.7%
RAREUltragenyx Pharmaceutical Inc.$66.3M0.71%$42.07$33.47-20.4%
0.7%
KNSAKiniksa Pharmaceuticals International, plc$55.8M0.60%$19.78$64.53+226.2%
0.6%
IMTXImmatics N.V.$51.7M0.55%$7.11$9.95+39.9%
0.6%
CRSPCRISPR Therapeutics AG$51.5M0.55%$39.36$60.08+52.6%
0.6%
STOKStoke Therapeutics, Inc.$51.1M0.55%$11.03$32.70+196.5%
0.6%
IMCRImmunocore Holdings plc$44.7M0.48%$29.50$32.50+10.2%
0.5%
ROIVRoivant Sciences Ltd.$44.6M0.48%$11.83$35.13+197.0%
0.5%
SERASera Prognostics, Inc.$44.2M0.47%$8.14$2.00-75.4%
0.5%
IMVTImmunovant, Inc.$42.3M0.45%$24.77$38.79+56.6%
0.5%
XENEXenon Pharmaceuticals Inc.$39.0M0.42%$39.20$60.96+55.5%
0.4%

Attività Trimestre su Trimestre

Q4 2024 vs. Q3 2024

Nuove Posizioni (8)

TickerEmittenteNozionale
Ionis Pharmaceuticals, Inc.$29.5M
GRALGRAIL, Inc.$29.1M
CADLCandel Therapeutics, Inc.$25.9M
VIRVir Biotechnology, Inc.$8.0M
NTLAIntellia Therapeutics, Inc.$7.5M
BNTXBioNTech SE$5.1M
IRONDisc Medicine, Inc.$4.9M
DBVTDBV Technologies S.A.$4.5M

Posizioni Chiuse (8)

TickerEmittenteNozionale
TNGXTango Therapeutics, Inc.$5.8M
CRNXCrinetics Pharmaceuticals, Inc.$5.3M
DBVTDBV Technologies S.A.$5.1M
ALECAlector, Inc.$4.3M
NAMSNewAmsterdam Pharma Company N.V.$1.6M
AVTEAerovate Therapeutics, Inc.$1.3M
PFEPfizer Inc.$1.0M
BCRXBioCryst Pharmaceuticals, Inc.$0.6M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
GPCRStructure Therapeutics Inc.$6.0M+322.9%
IONSIonis Pharmaceuticals, Inc.$3.6M+60.2%
CRSPCRISPR Therapeutics AG$11.9M+55.1%+52.6%
MRUSMerus N.V.$3.9M+50.0%
NGNENeurogene Inc.$-3.7M+47.9%
CELCCelcuity Inc.$7.1M+42.9%
IMVTImmunovant, Inc.$7.4M+39.4%+56.6%
KALAKALA BIO, Inc.$3.3M+34.8%

Ridotte (4)

TickerEmittenteNozionaleVar. AzioniDal Deposito
BMEABiomea Fusion, Inc.$-15.7M-31.2%
SGMTSagimet Biosciences Inc.$0.5M-31.0%
ONCBeiGene, Ltd.$-612.2M-9.8%+61.1%
RYTMRhythm Pharmaceuticals, Inc.$5.4M-4.9%+104.0%
Torna agli Hedge Fund